| Sample | Title | Value | Rank |
|---|
| GSM303966 | SLE-7 #4 @12wks, asymptomatic (-2077090517) | 179.989 | 83 |
| GSM303972 | SLE-7 #3 @12wks, asymptomatic (-2077090523) | 164.952 | 82 |
| GSM303986 | SLE-7 #2 @12wks, asymptomatic (-2077090529) | 153.881 | 80 |
| GSM303991 | SLE-7 #1 @12wks, asymptomatic (-2077090535) | 170.697 | 82 |
| GSM303961 | SLE-7 #1 @36wks, asymptomatic on treatment with sirolimus (-2101366109) | 175.313 | 83 |
| GSM303979 | SLE-7 #3 @36wks, asymptomatic on treatment with sirolimus (-2101365196) | 140.574 | 78 |
| GSM303985 | SLE-7 #2 @36wks, asymptomatic on treatment with sirolimus (-2101365652) | 164.976 | 82 |
| GSM303971 | SLE-7 #2 @36wks, diseased/symptomatic (-2101366115) | 202.488 | 85 |
| GSM303973 | SLE-7 #1 @36wks, diseased/symptomatic (-2101366147) | 182.448 | 84 |
| GSM303980 | SLE-7 #3 @36wks, diseased/symptomatic (-2102085829) | 216.567 | 86 |
| GSM303962 | SLE-7 #3 @42wks, asymptomatic on treatment with sirolimus (-2101365164) | 142.469 | 79 |
| GSM303978 | SLE-7 #2 @42wks, asymptomatic on treatment with sirolimus (-2102085846) | 169.134 | 82 |
| GSM303982 | SLE-7 #1 @42wks, asymptomatic on treatment with sirolimus (-2101365170) | 222.14 | 87 |
| GSM303965 | SLE-7 #2 @42wks, diseased/symptomatic (-2102085823) | 210.407 | 86 |
| GSM303968 | SLE-7 #1 @42wks, diseased/symptomatic (-2101365185) | 172.844 | 82 |
| GSM303981 | SLE-7 #3 @42wks, diseased/symptomatic (-2101365176) | 207.92 | 85 |